Status | In progress |
Technology type | Device |
Decision | Selected |
Reason for decision | Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources |
Further information | In appraisal |
Process | Cost Comparison Standard |
ID number | 6376 |
Provisional Schedule
Expected publication | 03 July 2024 |
Project Team
Project lead | Louise Jafferally |
Email enquiries
- If you have any queries please email TATeam4@nice.org.uk
External Assessment Group | Centre for Reviews and Dissemination and Centre for Health Economics, University of York |
Stakeholders
Companies sponsors | Terumo Europe (QuiremSpheres) |
Others | Department of Health & Social Care |
NHS England | |
Patient carer groups | None |
Professional groups | Association of Cancer Physicians |
British Association for the Study of the Liver | |
Cancer Research UK | |
Royal College of Physicians | |
Royal College of Radiologists | |
Associated public health groups | None |
Comparator companies | Boston Scientific (TheraSphere) |
Sirtex Medical (SIR-Spheres) | |
General commentators | All Wales Therapeutics and Toxicology Centre |
British National Formulary | |
Department of Health, Social Services and Public Safety for Northern Ireland | |
Healthcare Improvement Scotland | |
Medicines and Healthcare products Regulatory Agency | |
Scottish Medicines Consortium | |
Welsh Government | |
Welsh Health Specialised Services Committee | |
Relevant research groups | Institute of Cancer Research |
Timeline
Key events during the development of the guidance:
Date | Update |
---|---|
12 December 2023 | Invitation to participate |
28 November 2023 - 04 December 2023 | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators |
27 November 2023 | The appraisal is expected to start during late November 2023 with a consultation on the draft scope. It is then anticipated that the final scope will be released along with an invitation to participate in the appraisal during mid-December 2023. |
24 November 2023 | In progress |
For further information on our processes and methods, please see our CHTE processes and methods manual